This article is part of “Dealing the Dead,” a series investigating the use of unclaimed bodies for medical research ... asked Boston Scientific if the biotech giant realized one of its ...

Researchers at University of Galway have developed a way of bioprinting tissues that change shape as a result of ...

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in mice, the biotech announced Dec. 23. The Texas-based company conducted ...

These assets include a product portfolio with trailing twelve-month revenue of approximately $2.5 million, as well as the commercial and product development team. Additionally, Carmell will ...

contributing to nearly half of all drugs in development. However, China’s influence in global R&D has grown significantly, with expanding clinical trial activity and first-to-market launches. All the ...

While only around 330 Boston-area biotech employees were impacted by layoffs in the first quarter of 2024, that number rose to over 1,810 workers in the second quarter and more than 1,400 people ...

A key development to watch ... including cancer and Alzheimer's. Early research has been promising. Seeking Alpha: Are there indications or a niche that biotech investors should focus on in ...

Ph.D. Velocity is a clinical research organization headquartered in Durham, North Carolina, with sites across the U.S. and Europe. In an email to Fierce Biotech, Evans said he expects rising costs ...